Latest News

25 August 2020
ECFG is an International conference on Fungal genetics, biology, host pathogen interaction & evolutionary ecology. It is a great pleasure to invite you to Innsbruck (Austria), from 5-8 March 2023 , for an exciting meeting, with an outstanding scientific program! The aim of ECFG16 is to showcase recent advances in fungal genetics and molecular biology, including cellular biology, omics technologies, host-pathogen interactions, evolutionary genomics, molecular ecology.
19 January 2020
Fungi feeding on other fungi (mycoparasites) represent a promising alternative to chemical fungicides for plant disease control. They also have potential applications in medicine and across industry. Dr. Susanne Zeilinger and her team (WG Zeilinger-Migsich) from the University of Innsbruck in Austria are working to identify and characterise the genes and gene products that are active during the interactions of antagonistic fungi. This critical work is paving the way for improvement of fungal strains as biotechnological workhorses in plant protection and beyond.

Search Mycology Tyrol

User Blog

Wolfgang Burgstaller - 25 January 2018

Wolfgang Burgstaller - 24 January 2018

Alexander Lichius - 20 April 2017

Wolfgang Burgstaller - 18 April 2017

Upcoming Events

16th European Conference on Fungal Genetics

March
Sunday
5
Sun, 5. March 2023 - Wed, 8. March 2023
Congress Innsbruck
Conference & Symposium
16th European Conference on Fungal Genetics ECFG is an International conference on Fungal genetics, biology, host pathogen interaction & evolutionary ecology. It is a great pleasure to invite you to Innsbruck (Austria), from 5-8 March 2023,…

OPATHY (from Omics of PATHogenics Yeasts) is an innovative translational research training network that will explore the potential of next-generation high-throughput technologies, including genomics, transcriptomics and proteomics, to study the interactions of yeasts that cause disease to humans (e.g. Candida and Cryptococcus sp.) with their host, and to develop new diagnostic tools to monitor yeast infections in the clinic.

Today, these infections are poorly understood, difficult to diagnose, and are becoming increasingly frequent and serious, affecting over 300 million people worldwide. Pressing problems are the emergence of resistance to anti-fungal drugs, the persistence in the host, and the lack of fast and efficient diagnostic tools to direct to the appropriate treatment. Recent developments in high-throughput genomics and proteomics techniques (omics) have revolutionized biomedical research but their potential for their use in the clinic remains poorly explored. OPATHY will exploit these technologies to investigate host-pathogen interactions during yeast infection and colonization with a primary focus on developing innovative diagnostics tools to improve health care. Proteomics, transcriptomics and genomics measurements of strains and infections will be integrated with state-of-the-art computational analyses to identify novel biomarkers that are able to determine the infection stage, the infective pathogen, and the potential resistance traits. This knowledge will drive the development of diagnostic tools based on the detection of specific DNA sequences (by PCR) or antibodies (by Elisa or proteomics).

These tools will be validated in a clinical study of key patient cohorts, and new diagnostic protocols will be assessed and disseminated to clinicians across Europe. The participation of two clinical centers and four companies is of paramount importance for the network to provide an integrative and transversal research and training environment for the Early Stage Researchers (ESRs), who will learn how to validate the approaches developed into clinical tools of the highest standards possible. Importantly, the methodologies and approaches of OPATHY can be easily extended to the study and identification of other human, animal and plant microbial pathogens, or the tracing of relevant industrial organisms. Therefore, the potential of our research extends beyond pathogenic yeasts and clinical applications. Grounded on solid individual research projects, OPATHY will train ESRs at network level in several scientific technologies and fields, as well as in transferable skills, which will kick start the careers of young, innovative and creative researchers. 

Further information: http://www.opathy.eu/project/research

Working group: WG Lass-Flörl